Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Barbara Ensoli, MD, Istituto Superiore di Sanità
ClinicalTrials.gov Identifier:
NCT00751595
First received: September 11, 2008
Last updated: August 8, 2014
Last verified: August 2014